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A B S T R A C T
Background
Mobile phone messaging, such as Short Message Service (SMS) and Multimedia Message Service (MMS), has rapidly grown into
a mode of communication with a wide range of applications, including communicating the results from medical investigations to
patients. Alternative modes of communication of results include face-to-face communication, postal messages, calls to landlines or
mobile phones, through web-based health records and email. Possible advantages of mobile phone messaging include convenience to
both patients and healthcare providers, reduced waiting times for health services and healthcare costs.
Objectives
To assess the effects of mobile phone messaging for communicating results of medical investigations, on people’s healthcare-seeking
behaviour and health outcomes. Secondary objectives include assessment of participants’ evaluation of the intervention, direct and
indirect healthcare costs and possible risks and harms associated with the intervention.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2009, Issue 2), MEDLINE
(OvidSP) (January 1993 to June 2009), EMBASE (OvidSP) (January 1993 to June 2009), PsycINFO (OvidSP) (January 1993 to June
2009), CINAHL (EbscoHOST) (January 1993 to June 2009), LILACS (January 1993 to June 2009) and African Health Anthology
(January 1993 to June 2009). We also reviewed grey literature (including trial registers) and reference lists of articles.
Selection criteria
We included randomised controlled trials (RCTs), quasi-randomised controlled trials (QRCTs), controlled before-after (CBA) studies,
or interrupted time series (ITS) studies with at least three time points before and after the intervention. We included studies assessing
mobile phone messaging for communicating results of medical tests, between a healthcare provider or ’treatment buddy’ and patient.
We only included studies in which it was possible to assess the effects of mobile phone messaging independent of other technologies
or interventions.
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Data collection and analysis
Two review authors independently assessed all studies against the inclusion criteria, with any disagreements resolved by a third review
author. Study design features, characteristics of target populations, interventions and controls, and results data were extracted by two
review authors and confirmed by a third. Primary outcomes of interest were health outcomes and healthcare utilisation as a result of
the intervention. We also considered patients’ and providers’ evaluation of the intervention, perceptions of safety, costs and potential
harms or adverse effects of the intervention.
Main results
We included one randomised controlled trial involving 2782 participants. The study investigated the effects of mobile phone messaging
in alleviating anxiety in women waiting for prenatal biochemical screening results for Down syndrome, by providing fast reporting
of results before a follow-up appointment. The study measured health outcomes using the Spielberger State-Trait Anxiety Inventory
(STAI), which includes a scale (20 to 80 points, higher score indicates higher anxiety) to describe how the respondent feels at a particular
moment in time (state anxiety). The study, which was at high risk of bias, found that women who had received their test result early
by text message had a mean anxiety score 2.48 points lower than women who had not yet received their result (95% CI - 8.79 to
3.84). Women with a serum-negative test result receiving their result early had a mean anxiety score 5.3 points lower (95% CI - 5.99
to -4.61) than women in the control group. Women with a serum-positive test result receiving their result early by text message had a
mean anxiety score 1.2 points higher (95% CI - 3.48 to 5.88) than women in the control group.The evidence was of low quality due
to high risk of bias in the included study, and the fact that the evidence comes from one study only. The study did not report on other
outcomes of interest, such as patient satisfaction, adverse events or cost.
Authors’ conclusions
We found very limited evidence of low quality that communicating results of medical investigations by mobile phone messaging may
make little or no difference to women’s anxiety overall or in women with positive test results, but may reduce anxiety in women with
negative test results. However, with only one study included in this review, this evidence is insufficient to inform recommendations at
this time. More research is needed on the effectiveness and user evaluation of these interventions. In particular, more research should
be conducted into the potential risks and limitations of these interventions.
P L A I N L A N G U A G E S U M M A R Y
Mobile phone messaging for communicating results of medical investigations
Mobile phones offer a way to communicate information quickly through simple, short text messages. This review studied whether
mobile phone applications such as Short Message Service (SMS) and Multimedia Message Service (MMS) can be useful to send
information to patients about their test results. We also looked at possible risks of communicating in this way. Our review found only
one study evaluating the use of mobile phone messaging for communicating results of medical investigations. This study was at high
risk of bias. The study suggested that the early communication of an antenatal screen test result by text messaging would not result in a
difference in the anxiety scores of all pregnant women (irrespective of the test result) or when their test result is positive, however may
reduce anxiety in pregnant women when their test result is negative. The usefulness of mobile phone messaging in other situations, or
potential negative consequences, are not yet known.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Early communication of result from prenatal serum screening for Down syndrome by mobile phone messaging compared to
standard care
Patient or population: Pregnant women undergoing prenatal serum screening for Down syndrome
Settings: One district general hospital in Taiwan
Intervention: The test result from prenatal screening is communicated early, i.e. before the scheduled clinic appointment, by mobile
phone messaging
Comparison: The test result from prenatal screening is communicated directly only at the time of the scheduled clinic appointment
Outcomes Illustrative comparative risks* (95% CI) No of Participants
(studies)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Standard care Mobile phone messag-
ing
State anxiety score before scheduled clinic appointment (that is, when the intervention group had already received the test result
by SMS)
Overall effect (i.e. irre-
spective of screening re-
sult)
The mean anxiety score
for the control group was
39.2 (SD 10.2)
The overall mean state
anxiety score in the inter-
vention group was 2.48
lower (8.79 lower to 3.84
higher).
2782
(1 study)
⊕⊕©©
low1
Serum-negative group The mean anxiety score
for the control group was
39.1 (SD 10.1)
The mean state anxiety
score for the serum-neg-
ative group in the in-
tervention group was 5.
30 lower (5.99 to 4.61
lower).
2673
(1 study)
⊕⊕©©
low1
Serum-positive group The mean anxiety score
for the control group was
42.9 (SD 11.5)
The mean state anxiety
score for the serum-pos-
itive group in the inter-
vention group was 1.20
higher (3.48 lower to 5.
88 higher).
109
(1 study)
⊕⊕©©
low1
Other outcomes
Health-seeking behaviour Not measured
Patient’s evaluation of
the intervention (including
perceptions of safety)
Not measured
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Harms & adverse effects Not measured
Costs Not measured
*The basis for the assumed risk (the mean control group risk across studies) is provided above. The corresponding risk (and its 95%
confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 High or unclear risk in three of the six risk of bias domains (serious limitations in study design)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
Mobile phone messaging is an important means of human com-
munication globally. Mobile phone penetration is rapidly increas-
ing particularly in the Asia-Pacific region, with 90% of the global
and 80% of rural population having access to a mobile network in
2010. The number of subscriptions in 2010 reached 5.3 billion,
representing a 76.2% global penetration rate (ITU 2010). The
penetration rates are 70% to 90% in high-income countries, with
a similar rate of increase across all socio-economic groups (Atun
2006).
Most digital mobile phones provide ShortMessage Service (SMS),
also known as text messaging, and Multimedia Message Service
(MMS) for transmitting graphics, video clips and sound files.
SMS, in particular, has rapidly developed into a powerful com-
munication medium, particularly among young adults. The total
number of text messages sent globally tripled between 2007 and
2010, from an estimated 1.8 trillion to 6.1 trillion, with about
200,000messages sent every second (ITU 2010). These shortmes-
sages, where up to 160 characters of text are sent from the In-
ternet or from a mobile phone to one or several mobile phones,
could provide an important, inexpensive medium of communi-
cation. The terms text message, text, or txt are more commonly
used in North America, the UK, Spain and the Philippines, while
in many other countries the term SMS is used. In this review we
will use the term ‘text messaging’ to refer to the use of SMS only,
distinguishing it from the term ‘mobile phone messaging’, which
encompasses both SMS and MMS. Increasingly, the latter term
also refers to mobile e-mail and ‘instant messaging’ delivered to
the mobile phone.
Text messages, compared to other communication channels, have
the advantage of instant transmission and low cost. There is also
a smaller chance of being misplaced compared to print materi-
als, and of being invasive to daily lives compared to phone calls
(Kaplan 2006). Features such as ubiquity, mobility, direct and in-
stantaneous access and direct communication offer the possibil-
ity of using mobile phones for health information transfer (Atun
2006). A literature review on the use of mobile phones in health
care has demonstrated thewide application andpotential ofmobile
phones to: increase access to health care; enhance efficiency of ser-
vice delivery; improve diagnosis, treatment and rehabilitation; and
support public health programmes (Atun 2006; Car 2008b). Mo-
bile phone messaging has, for example, been used to provide ap-
pointment reminders (Bos 2005), to improve patient compliance
with medications (Fairley 2003; Marquez Contreras 2004; Vilella
2004), to monitor chronic conditions (Ferrer-Roca 2004; Kwon
2004; Ostojic 2005) and to provide psychological support (Bauer
2003; Franklin 2003). Mobile phones have also been used inman-
aging communicable diseases (e.g. in contact tracing and part-
ner notification for sexually transmitted illnesses (Newell 2001))
and in health promotion programmes (e.g. in smoking cessation
(Obermayer 2004; Rodgers 2005)). Furthermore, the use of mo-
bile phones has been shown to improve service utilization among
population groups such as teenagers and young adult males who
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do not typically use health services, by providing the opportunity
to remotely access care providers for advice (Atun 2006b). How-
ever, for older adults, some of whom are less able or willing to use
mobile phones, the effect on improved service utilization could be
limited (Atun 2006b).
Challenges in using mobile phone applications in health care in-
clude incomplete coverage of mobile networks across regions, lack
of standards, and possible information overload (Adler 2007).
This review is part of a series of four reviews which aim to de-
termine the effects of mobile phone messaging in improving the
processes of healthcare service delivery and service utilization.
We divided the reviews into four areas based on the specific inter-
ventions and related outcomes:
• Mobile phone messaging for communicating results of
medical investigations (this review);
• Mobile phone messaging for preventive health care
(Vodopivec-Jamsek 2008);
• Mobile phone messaging reminders for attendance at
healthcare appointments (Car 2008);
• Mobile phone messaging for facilitating self-management
of long-term illnesses (de Jongh 2008).
Description of the condition
In this review, we include all conditions that may require medical
investigation. Medical investigations can be defined as tests used
for screening, diagnosis andmonitoring of disease. Some examples
of medical investigations are: blood, urine and stool tests; medical
imaging; and medical radiology.
Description of the intervention
For communicating results of medical investigations, seven pos-
sible modes of communication are: face-to-face, postal message,
call to landline, call to mobile, via web-based electronic health
records (EHR), email and SMS/MMS. Basic characteristics and
a comparison with alternative modes of communication are out-
lined in Table 1 (adopted from Atun 2006). Although the most
common route of communication is from the health provider to
the patient, other routes are possible to enhance access, such as
from a laboratory to the health professional in a rural clinic.
Some applications of SMS/MMS technology reported to date in
high-income countries include: communicating the results of in-
vitro diagnostic tests, such as bloodormicrobiology tests (Bradbeer
2003); and radiological imaging such as breast cancer screening
(Lamont 2005). In low-income countries the applications are po-
tentially more diverse, as there are greater barriers to accessing
healthcare facilities. Some applications reported to date include
sending results to clinics in rural areas more efficiently, and ex-
pediting the communication of occupational health examination
results of foreign workers to their employers (Atun 2006).
How the intervention might work
Effective communication involves accurate and timely transmis-
sion of result to correct recipients, securing privacy and confiden-
tiality, and using strategies to minimise misunderstanding or mis-
interpretation of the results. The healthcare provider should also
ensure that appropriate follow-up actions are taken once the result
is known, such as further investigation, change of treatment, or
setting a new date for review and an explanation of what the result
means.
Traditional approaches to communicating results of medical in-
vestigations and diagnoses to patients often require patients to
visit the healthcare provider and collect the results in person. In
circumstances where visiting the healthcare provider is inconve-
nient for the patient, for example, because there are significant
transportation costs or the patient’s health status is poor, SMS/
MMS interventions are likely to result in reduced waiting times
and cost-savings for patients and healthcare providers, increased
convenience and satisfaction, and an improved access to services
(Lovitt 2005; Pal 1998). Sending results by SMS/MMS is faster
than by other means and adheres to privacy and confidentiality
requirements if the mobile phone is a personal device and the con-
tact details in the health records are accurate.
Acceptability and risks of the intervention
One study related to patient preferences regarding notification of
test results identified privacy, responsive and interactive feedback,
convenience, timeliness, and provision of details as themain issues
(Baldwin 2005). Preferences for particular modes of communica-
tion were mixed (Baldwin 2005; Lin 2005; Meza 2000; Schofield
1994). With regard to newer technologies, studies have reported
positive responses to communicating test results using web mes-
saging and electronic health records (Hassol 2004; Kleiner 2002;
Liederman 2003; Lin 2005; Ralston 2007). Studies in which pa-
tients and/or providers rated text messaging for promoting disease
self-management positively, noted features of simplicity and time-
liness of the intervention (Ferrer-Roca 2004; Pinnock 2006). On
the other hand, some skepticism was reported regarding clinical
benefits, time and cost implications (Pinnock 2006). In addition,
participants’ perceptions of personal invasion andbehavioural con-
trolmay be affected by inappropriate SMS initiationmethods, and
the intervention may have the opposite effect of that intended.
Possible risks of using mobile phone messaging include the risk of
inaccurate data input (Norwell 2003), lack of understanding or
misinterpretation of the information, and difficulties in reading
for those with poor vision or problems with literacy. Furthermore,
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mobile phone messaging is intended to support or complement
the process of care delivery rather than to substitute for it. A possi-
ble risk of a narrow focus on the technology is that providers may
misinterpret it as an endpoint to their responsibilities within the
care delivery process, believing that their work is completed once
the message is sent. This may result in inadequate follow-up of pa-
tients after the intervention. Additionally, text messaging cannot
capture the verbal and non-verbal cues that may also influence the
interpretation of the message. Physicians sending abnormal test
results in particular may fail to immediately fulfil patient needs in
term of explanation of the implications of the results, prognosis
and treatment options. Patient safety may also be compromised
after receiving information on abnormal results if the information
is not acted upon appropriately. The psychological and social im-
pacts of using the mobile phone in this way are other key issues.
Having correct patient contact information and securely stored
health records are essential tomeet privacy, confidentiality anddata
protection requirements. Failures or delays in message delivery are
rare but possible; however, harm is unlikely as senders are usually
notified instantly in cases of a transmission problem. There may
be additional monetary and time costs, as backup systems may be
needed. Lastly, risks associated with mobile phone messaging in
general may apply, for instance increased risk of car accidents as a
result of messaging whilst driving.
Why it is important to do this review
Although there is some evidence on the use and effectiveness of
mobile phone messaging in healthcare delivery, answers to ques-
tions regarding the implementation of these technologies in rou-
tine care, such as their impact on patient-related outcomes or on
processes of healthcare delivery, are unclear. Given the topical na-
ture of the subject, we conducted this review to identify answers
to these questions and propose directions for future research. This
review complements available studies on the use of telephone con-
sultations (Car 2003), email (Car 2004; Car 2004b) and personal
digital assistants (PDAs) (Baumgart 2005) in health care, as well
as forthcoming Cochrane reviews on mobile phone messaging for
a range of purposes (Car 2008; de Jongh 2008; Vodopivec-Jamsek
2008).
O B J E C T I V E S
To assess the effects of mobile phone messaging for communicat-
ing results of medical investigations on people’s healthcare-seeking
behaviour and health outcomes. Secondary objectives include as-
sessment of participants’ evaluation of the intervention, direct and
indirect healthcare costs and possible risks and harms associated
with the intervention.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs), quasi-ran-
domised controlled trials (QRCTs), controlled before and after
studies (CBAs), and interrupted time series (ITS) with at least
three time points before and after the intervention.
We define a QRCT as a controlled trial in which the participant
allocation is not truly random, such as allocation by date of birth
or the order in which participants are included in the study. We
included QRCT, CBA and ITS designs because our initial liter-
ature searching suggested that only a small number of RCTs on
mobile phone messaging interventions exist.
Types of participants
We included all study participants regardless of age, gender and
ethnicity, as well as all types and stages of diseases. We included
studies in all settings, i.e. primary care settings (services of primary
health care), outpatient settings (outpatient clinics), community
settings (public health services, anywhere where a person can use
a mobile phone) and hospital settings. We did not exclude studies
according to the type of healthcare provider (e.g. nurse, doctor,
allied staff ).
Types of interventions
We included interventions using SMS or MMS for communicat-
ing results of medical tests, regardless of the purpose of the test
(screening, diagnostic, guide to treatment, monitoring etc.). The
messaging needed to be between a healthcare provider (either in
person or automated) or a ’treatment buddy’ (e.g. a lay health
worker or peer supporter) and a patient, regardless of who sent the
first message.
We excluded studies of mobile phone messaging to people other
than those who were notified of their medical investigations, or
messaging between two healthcare providers. We also excluded
studies in which mobile phone messaging was a part of a multi-
faceted intervention, as it would not be possible to separate the
effects of messaging alone.
We aimed to make comparisons betweenmobile phone messaging
and no intervention, as well as other modes of communication
such as face-to-face, postal letters, calls to landline or mobile tele-
phones, email or via electronic health records; and if applicable,
automated versus personal text messaging.
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Types of outcome measures
A number of processes and outcomes may be affected by inter-
ventions that aim to enhance and/or facilitate the communication
between patients and/or carers, and healthcare providers (individ-
uals or institutions) using mobile phone messaging. We sought all
relevant outcomes relating to the following categories:
Primary outcomes
• Healthcare-seeking behaviour in response to the
intervention, including utilisation of, and time to contact, health
provider;
• Health outcomes as a result of the intervention, including
physiological measures, clinical assessments, biomarker values,
self-reporting of symptom resolution, and quality of life.
Secondary outcomes
• User (patient, carer or healthcare provider) evaluation of the
intervention, including satisfaction, readiness to use, timeliness,
availability and/or convenience;
• User (patient, carer or healthcare provider) perceptions of
safety;
• Potential harms or adverse effects of the intervention, such
as misreading or misinterpretation of the test results,
transmission of inaccurate data, loss of verbal and non-verbal
communication cues, issues of privacy and disclosure, or failure
or delay in the message delivery;
• Healthcare costs (direct and indirect) of the intervention.
Search methods for identification of studies
We used a common search strategy for all four reviews (Car 2008;
de Jongh 2008; Vodopivec-Jamsek 2008), and allocated relevant
studies to their respective reviews before assessing their risk of bias
and extracting data. A study may be relevant to, and included in,
more than one review.
The search strategies for each database are given in Appendix 1 to
Appendix 7.
Electronic searches
We restricted the searches to studies published since 1993 as
the first commercial SMS message was sent in December 1992
(Wikipedia 2007). We included LILACS and the African Health
Anthology because mobile phone messaging applications are in-
creasingly used in low- and middle-income regions. There were
no language restrictions.
One review author (IGU) searched the following electronic
databases on October 13, 2008 and updated the search on June
22, 2009:
• The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library 2009, issue 2);
• MEDLINE (OvidSP) (January 1993 to June 22, 2009);
• EMBASE (OvidSP) (January 1993 to June 22, 2009);
• PsycINFO (OvidSP) (January 1993 to June 22, 2009);
• CINAHL (EbscoHOST) (January 1993 to June 22, 2009);
• LILACS (January 1993 to June 22, 2009);
• African Health Anthology (January 1993 to June 22, 2009).
Searching other resources
For grey literature we searched:
• Proceedings from AMIA Congresses;
• WHO Clinical Trial Search Portal (www.who.int/
trialsearch);
• Current Controlled Trials (www.controlled-trials.com);
• Dissertation Abstracts International.
We searched the reference lists of included studies to identify addi-
tional studies. We contacted study authors for further information
on their studies and to enquire whether they were aware of any
other published or ongoing studies that would meet our inclusion
criteria.
Data collection and analysis
Selection of studies
The selection of studies was done by IGU, TdJ and VVJ. IGU
and TdJ independently assessed the relevance of all titles and ab-
stracts identified from the electronic searches. We retrieved full
text copies of all articles judged to be potentially relevant from
the titles and abstracts. TdJ and VVJ independently assessed these
articles for inclusion. IGU checked the final list of included and
excluded studies, and any disagreements were resolved by discus-
sion with VVJ, JC, and RA. Where the description of the inter-
vention was not sufficiently detailed to allow the review authors
to judge whether it met the inclusion criteria, we contacted the
study authors for further details.
Data extraction and management
We sought to extract the following data from the included study,
using a modified version of the Cochrane Consumers and Com-
munication Review Group’s data extraction template:
1. General information: title, authors, source, publication
status, date published, language, review author information, date
reviewed.
2. Study methods: aims of intervention, aim of study, study
design, methods of participant recruitment, inclusion/exclusion
criteria, informed consent and ethical approval, funding.
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3. Risk of bias: data depended on the study design (see
’Assessment of risk of bias in included studies’).
4. Participants: description, geographic location, setting,
number, age, gender, ethnicity, socio-economic status. If
relevant: principal health problem or diagnosis, stage of illness,
treatment received.
5. Providers: description, geographic location, setting, age,
gender.
6. Interventions: description including technical specifications
on SMS and handset provider, duration of intervention, purpose
of intervention, initiator of intervention, message content,
details of control/usual or routine care, co-interventions.
7. Outcomes: primary and secondary outcomes as specified at
Types of outcome measures, methods of assessing outcomes,
follow up for non-respondents, timing of outcome assessment,
adverse events.
8. Results: all reported measurements for the primary and
secondary outcomes, including multiple timings for
measurements, subgroup analyses or results in different
measurement scales if applicable.
Two review authors (TdJ, VVJ) independently extracted the above
data onto a standard form. The forms were then assessed by one
review author (IGU) who checked these data. Any discrepancies
between the two data extraction sheets were discussed by two re-
view authors (TdJ, VVJ) and resolved jointly with the two other
review authors (IGU and JC). For missing data, we contacted the
study authors to obtain the missing information.
Assessment of risk of bias in included studies
We assessed the risk of bias of included study in accordance with
the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011) which recommends the explicit reporting of se-
quence generation, allocation concealment, blinding of partici-
pants, providers and outcome assessors, incomplete outcome data,
selective outcome reporting and other sources of bias for RCTs.
Had studies using other study designs been identified for inclusion
in the review, we would have assessed these using a variation of
the above tool.
Two review authors (TdJ, VVJ) independently assessed the risk
of bias in the included study, with any disagreements resolved by
discussion and consensus of the team.We used a template to guide
the assessment of risk of bias, and judged each domain as ’yes’
(indicating a low risk of bias), ’no’ (indicating a high risk of bias)
or ’unclear’ (indicating an uncertain risk of bias).
We have presented the results of the risk of bias assessment in a
table, and provided a narrative discussion of risk of bias in indi-
vidual domains.
Measures of treatment effect
We used risk ratios (RR) as effect measures for dichotomous out-
comes and mean differences (MD) for continuous outcomes. RR
and MDs have been derived from Manzel-Haenszel and inverse
variance methods respectively. We used a random-effects model,
where possible, to pool the results and reported 95% confidence
intervals with all measures of effect.
Unit of analysis issues
We noted the method of randomisation in the included trial. We
would have considered additional issues regarding the assessment
of risk of bias of cluster randomised trials as discussed in Chap-
ter 16 of the Cochrane Handbook (Higgins 2011). In the case of
repeated measurements, we would have defined several outcomes
based on different periods of follow-up and performed separate
analyses for each outcome. In studies with more than two treat-
ment groups, wewould havemademultiple pair-wise comparisons
between all possible pairs of intervention groups.
Dealing with missing data
We contacted the original investigators to request missing data.
With incomplete outcome data (such as drop-outs, loss to follow-
up and withdrawn study participants), we assessed and reported
the risk of bias as high/unclear/low as guided by the Cochrane
Handbook (Higgins 2011) and identified the numbers as well as
the reasons for incomplete data. As the numbers and reasons for
incomplete outcome data in the included study suggested that data
were missing at random, we used only available data in the review
and did not use imputation methods.
Assessment of reporting biases
Wewere unable to assess reporting bias statistically or using funnel
plots, as we included only one study.We assessed selective outcome
reporting using the Cochrane Risk of Bias assessment tool.
Data synthesis
As only one study was included, we present a narrative overview
of the findings, including tabular summaries of extracted data.
Methods for combining results statistically have been retained (see
Appendix 8) for potential use in future updates of this review.
Subgroup analysis and investigation of heterogeneity
We conducted a post-hoc subgroup analysis according to differ-
ences in outcomes for participants who received positive versus
negative results from their medical investigations.
We were unable to conduct subgroup analyses by participant age
(0 to 18, 18 to 55, over 55), as planned, because only one study
was included.
8Mobile phone messaging for communicating results of medical investigations (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sensitivity analysis
We did not conduct the planned sensitivity analyses as only one
study was included. We had aimed to determine the influence of
the following factors on effect size:
• excluding unpublished studies;
• taking into account of risk of bias of included studies, as
specified above;
• excluding any large studies to establish how they impact on
the results;
• excluding studies using the following filters: criteria used
for clinical diagnosis and eligibility for intervention, language of
publication, source of funding (industry versus other), country;
• the length of the interval between delivery of the
intervention and measurement of the effect.
Consumer participation
The draft review was circulated for peer review by consumers in
TheCochraneCollaboration.The review received comments from
two consumers through the Cochrane Consumers and Commu-
nication Review Group’s standard editorial process. We also ex-
amined whether consumers were involved in the design and im-
plementation of each included study.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Our search (across all four reviews) identified 3937 citations. We
excluded 3750 citations that, based on the abstract alone, showed
insufficient relevance to the suite of reviews or did not meet the
stated study design criteria. After review of the full text of the
remaining 187 citations, a further 184 were subsequently rejected
from this review for failing to meet the inclusion criteria. In the
final selection stage, 2 of the remaining 3 citations were excluded
from this review as both were observational studies, one with an
historical control group. We did not identify any ongoing studies
relevant to this review.
Included studies
Only one study was included in this review (Cheng 2008).
We present key characteristics of this study below and in the
Characteristics of included studies table.
Methods
The included study was a randomised controlled trial (RCT). The
unit of randomisation was the individual participant. Study dura-
tion was 24 months from January 2005 to December 2006. The
study compared the effects of the text messaging intervention to
usual care.
Participants
Cheng 2008 was set in a department of gynaecology and obstet-
rics in a Taiwanese general hospital. Participants were pregnant
women of all ages who could speak Chinese and who were attend-
ing a routine second-trimester Down syndrome screening. Among
3691 potential participants, 3178 gave consent to participate in
the study. Of these, 88% (n = 2782) completed anxiety ques-
tionnaires at all three measurement points: (1) before the prenatal
screening, (2) after screening but before the clinic appointment,
and (3) three days after the clinic appointment. No further infor-
mation was provided on the 396 women who did not complete all
the questionnaires. The study found no significant differences be-
tween the intervention and control groups regarding age, marital
status, parity, education, occupation, total family income, propor-
tion of planned/unplanned pregnancies, previous pregnancy with
congenital abnormality, or gestational age at serum screening.
Interventions
Purpose
The purpose of the intervention was to provide fast communica-
tion of results via text messaging before the follow-up appoint-
ment, with the purpose to alleviate anxiety in women waiting to
receive results of prenatal screening for Down syndrome.
Specifications
An Internet Service Provider (ISP) handled the transmission of
screening results data from a modified web server to the mobile
phones of the intervention recipients.
Message content
The study does not report the exact content or format of the text
message used. The authors state that it was derived from the data
that contained the results of the screening. The study did not pro-
vide detailed information on the timing of the intervention rela-
tive to either the initial screening or the follow-up appointment.
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Outcomes
Cheng 2008 measured participant anxiety levels (1) before the
prenatal screening, (2) after screening but before the clinic ap-
pointment, and (3) three days after the clinic appointment. Anx-
iety levels were measured with the Spielberger State-Trait Anxiety
Inventory (STAI), which includes two scales to describe how the
respondent feels at a particular moment in time (state-anxiety)
and how the respondent generally feels (trait-anxiety). The scales
ranged from 20 to 80 points, with higher scores indicating higher
anxiety.
Risk of bias in included studies
Risk of bias in the included study is summarised in Figure 1.
Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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The study reported the use of an adequate sequence generation
method (computer generated random allocation sequences). Al-
though not stated in the study, we assume that no blinding of
participants, healthcare providers or outcome assessors took place.
The authors do not mention whether allocation concealment
methods were used. This could have introduced a source of bias.
Because we were not able to review the original study protocol, we
cannot fully exclude the possibility of selective reporting. How-
ever, this would appear to be unlikely as the study objective was
narrowly formulated as investigating the effects of early commu-
nication of test results on the women’s anxiety in the period be-
tween screening and a clinic appointment. This outcome measure
was fully reported. Intervention and control groups were reported
to be comparable on patient characteristics such as women’s age,
marital status, parity, education, occupation, and total family in-
come, although the supporting data for this claim were not re-
ported. In addition to the state anxiety scores measured before the
clinic appointment (that is, the variable of interest), trait and state
anxiety scores were measured both before the prenatal test and
three days after the final clinic appointment when both groups of
women had received the full test results. There were no significant
differences on these scores between the groups.
Analysis did not follow intention-to-treat (ITT) principles as data
were analysed only for women who had completed all three ques-
tionnaires. The study did not report reasons for loss to follow-up,
or discuss how this could have influenced outcomes.
We contacted the study authors for further information, but did
not get a response.
Effects of interventions
See: Summary of findings for the main comparison
Mobile phone messaging for communicating results of medical
investigations
In Cheng 2008, whenmeasured before a scheduled clinic appoint-
ment, women who had received their test result early by text mes-
sage had a mean anxiety score 2.48 points lower than women who
had not yet received their result (95% CI - 8.79 to 3.84) Analysis
1.1). However, of the total participants (n = 2782), those women
with a serum-negative test result receiving their result early had
a mean anxiety score 5.3 points lower (95% CI - 5.99 to -4.61)
than women in the control group. Those women with a serum-
positive test result receiving their result early by text message had
a mean anxiety score 1.2 points higher (95% CI - 3.48 to 5.88)
than women in the control group (Summary of findings for the
main comparison).The evidence was of low quality due to high
risk of bias in the included study, and the fact that the evidence
comes from one study only.
The study did not evaluate other important outcomes, such as
healthcare-seeking behaviour in response to the intervention, pa-
tient satisfaction or cost.
D I S C U S S I O N
Summary of main results
Our review found only one study assessing the effects of mobile
phone messaging for communicating results of medical investi-
gations. In this study (Cheng 2008) SMS was used to provide
pregnant women the results from prenatal screening for Down’s
syndrome before their next clinic appointment. Across all women,
the study showed that early reporting of test results by SMS may
have made little or no difference to anxiety. The intervention may
have reduced anxiety in pregnant women who received a serum-
negative result, but may have made little or no difference to anxi-
ety in women who received a serum-positive result.
Overall completeness and applicability of
evidence
We systematically collected and analysed the evidence to date on
the potential for mobile phone messaging in communicating re-
sults of medical investigations. Only one study met the inclu-
sion criteria. In selecting studies for inclusion we have deliberately
taken a rather narrow focus: only those studies where the inter-
vention is delivered exclusively through mobile phone messaging
were eligible. Studies in which mobile phone messages were com-
bined with other forms of data transmission, such as e-mail, In-
ternet or General Packet Radio Service (GPRS), were excluded, as
it would have been difficult to assess the independent effect of the
text message within such complex interventions. However, this
strategy restricted the body of evidence we were able to identify,
as we found that many studies in the area of mobile health have
relied on multifaceted interventions in which text messaging was
combined with other technologies.
Quality of the evidence
The study we included was of low methodological quality with
high risk of bias. The review’s results, therefore, do not provide
a robust foundation upon which to build recommendations for
the use of mobile phone messaging to communicate the results of
medical investigations.
Potential biases in the review process
We believe that we identified all studies concerning the use of mo-
bile phone messaging for communicating results of medical inves-
tigations that met our study design criteria (RCT, QRCT, CBA,
ITS) up to June 2009. However, by excluding studies with pos-
sible confounding from other communication and/or data trans-
mission methods, we may have introduced selection bias towards
less successful interventions, as more complex interventions may
be more effective at communicating results of medical investiga-
tions.
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Agreements and disagreements with other
studies or reviews
This review comes in the wake of two other reviews that analyse
text messaging interventions. Fjeldsoe 2009 reviewed the evidence
for behavioural change interventions delivered by SMS, whereas
Krishna 2009 more broadly looked at healthcare delivery via mo-
bile phones in the management and prevention of disease. Neither
of the studies commented on the interventions for communicat-
ing results of medical investigations.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Reliable conclusions on the effects of text messaging in commu-
nicating results of medical investigations cannot be drawn, based
on the one study we found.The low quality evidence from this
study suggests that sending negative (clear) screening results by
text message may reduce anxiety, but that sending positive (con-
cerning) results by text message may make little or no difference
to anxiety. Health service providers may wish to consider the im-
plications of these findings when implementing new approaches
to communicating test results to patients.
Implications for research
This review shows that there is currently insufficient evidence re-
garding the benefits and risks associated with mobile phone mes-
saging for communicating results of medical investigations. Evi-
dence is limited to one randomised controlled trial.
Future research should utilise randomised controlled trials to en-
sure robustness and minimise bias and should report on interme-
diate indicators such as health-seeking behaviour (which correlate
with health outcomes), patients’ evaluation of the intervention,
costs, economic benefits, and potential adverse effects. The latter
may be particularly important in instances where mobile phone
messaging is used to communicate test results which are poten-
tially upsetting to the patient, e.g. when patients test positive for
certain conditions.
As the timing of the message along the care pathway (for example
at screening stage or for control of established disease), frequency
of the messaging, the message content and the length of message,
as well as mode of communication, can affect outcomes, future
studies should clearly describe the intervention with reference to
the message attributes.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cheng 2008
Methods Study design: RCT
Participants Taiwan. Department of Gynecology and Obstetrics in one district general hospital. 3691
women who could speak Chinese and who agreed to undergo a Down syndrome screen-
ing test were eligible to participate. 3178 gave consent. 2782 completed the question-
naires on all three occasions
Baseline comparability: Age, marital status, parity, education, occupation, and total fam-
ily income, planned/unplanned pregnancy, previous pregnancy with congenital abnor-
mality, gestational age at which the serum screening was done [as stated in the publica-
tion, no data provided]
Interventions All pregnant women were given appointments for regular clinical follow-up after the
serum screening during which the information regarding results was communicated
SMS group: Women received fast reporting of the screening results via SMS before the
routine appointment
Control group: Fast reporting by SMS was not provided, women were informed about
their results during the clinic follow-up
Outcomes Anxiety levels using the Spielberger State-Trait Anxiety Inventory measured before pre-
natal screening, before clinic appointment and three days after clinic appointment
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random number system.
Allocation concealment (selection bias) Unclear risk No information on concealment.
Blinding (performance bias and detection
bias)
All outcomes
High risk No information of blinding of providers or researchers provided.
Blinding of participants not possible due to nature of interven-
tion. Unlikely to influence outcome measures
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 396 women did not complete the questionnaires on all occa-
sions. No further data are provided on whether the missing in-
formation is balanced across the intervention and control groups
Selective reporting (reporting bias) Low risk Protocol is not available. However, the outcome measure re-
ported (state anxiety before the clinic appointment) is consistent
with the objective of the study
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Cheng 2008 (Continued)
Other bias Low risk The authors state that the groups were comparable at baseline
on demographic variables, although no supporting data are pro-
vided. The intervention groups are comparable on trait and state
anxiety scores measured at baseline and 3 days after the clinic
appointment
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Lim 2008 Study design: Cohort study with historical control
Menon-Johansson 2006 Study design: Observational study
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D A T A A N D A N A L Y S E S
Comparison 1. State anxiety scores, before clinic appointment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cheng 2008 [combined] 1 2782 Mean Difference (IV, Random, 95% CI) -2.48 [-8.79, 3.84]
1.1 Cheng 2008
[Serum-negative]
1 2673 Mean Difference (IV, Random, 95% CI) -5.30 [-5.99, -4.61]
1.2 Cheng 2008
[Serum-positive]
1 109 Mean Difference (IV, Random, 95% CI) 1.20 [-3.48, 5.88]
Analysis 1.1. Comparison 1 State anxiety scores, before clinic appointment, Outcome 1 Cheng 2008
[combined].
Review: Mobile phone messaging for communicating results of medical investigations
Comparison: 1 State anxiety scores, before clinic appointment
Outcome: 1 Cheng 2008 [combined]
Study or subgroup Early SMS reporting Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Cheng 2008 [Serum-negative]
Cheng 2008 1366 33.8 (7.9) 1307 39.1 (10.1) 56.6 % -5.30 [ -5.99, -4.61 ]
Subtotal (95% CI) 1366 1307 56.6 % -5.30 [ -5.99, -4.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 15.07 (P < 0.00001)
2 Cheng 2008 [Serum-positive]
Cheng 2008 56 44.1 (13.4) 53 42.9 (11.5) 43.4 % 1.20 [ -3.48, 5.88 ]
Subtotal (95% CI) 56 53 43.4 % 1.20 [ -3.48, 5.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Total (95% CI) 1422 1360 100.0 % -2.48 [ -8.79, 3.84 ]
Heterogeneity: Tau2 = 18.21; Chi2 = 7.25, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 7.25, df = 1 (P = 0.01), I2 =86%
-10 -5 0 5 10
Favours SMS reporting Favours control
17Mobile phone messaging for communicating results of medical investigations (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A D D I T I O N A L T A B L E S
Table 1. Characteristics of communication modes
Face-to-face Postal Letter Call to Land-
line
Call to Mo-
bile
Web Based
(EHR)
E-mail SMS / MMS
Immediacy Slow: Re-
quires a visit to
provider
Slow: 2 days Immediate:
If person at
home. Return
call may be
necessary
Immediate:
If person
answers (more
likely than
landline)
Return call
may be neces-
sary
Immediate: Immediate
Or stored
Immediate
Or stored
Privacy and
Confidential-
ity
High:
Personal com-
munication
High:
Personally ad-
dressed
Low: Confi-
dentiality pre-
vents mes-
sage being left
as others may
answer or re-
trieve it
High:
Personal
device enables
possibility of
message being
left
Moderate:
Personal /
public device?
Moderate:
Personal /
public device?
High if
Personal
device.
Likelihood of
misinterpre-
tation
Low Moderate Low:
Patient can re-
quest immedi-
ate
clarification
Low:
Patient can re-
quest immedi-
ate
clarification
Moderate Moderate Moderate
Delivery con-
firmation
N/A Yes:
at significant
expense
Unnecessary if
call answered.
No if message
left
Unnecessary if
call answered.
No if message
left
N/A Yes Yes
Cost High Moderate Low Moderate Low Low Low
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1. cellular phone/
2. text messag$.ab,ti.
3. texting.ab,ti.
4. short messag$.ab,ti.
5. sms.ab,ti.
6. (multimedia messag$ or multi-media messag$).ab,ti.
7. mms.ab,ti.
8. ((cellular phone$ or cell phone$ or mobile phone$) and (messag$ or text$)).ab,ti.
9. or/1-8
10. randomized controlled trial.pt.
11. controlled clinical trial.pt.
12. randomized controlled trials.sh.
13. random allocation.sh.
14. double blind method.sh.
15. single blind method.sh.
16. or/10-15
17. animals/ not (human/ and animals/)
18. 16 not 17
19. clinical trial.pt.
20. exp clinical trials/
21. (clin$ adj25 trial$).ti,ab.
22. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
23. placebos.sh.
24. placebo$.ti,ab.
25. random$.ti,ab.
26. research design.sh.
27. or/19-26
28. 27 not 17
29. 18 or 28
30. exp evaluation studies/
31. follow up studies/
32. prospective studies/
33. (control$ or prospectiv$ or volunteer$).tw.
34. cross over studies/
35. comparative study/
36. or/30-35
37. experiment$.tw.
38. (time adj series).tw.
39. (pre test or pretest or (posttest or post test)).tw.
40. (pre intervention or preintervention or (post intervention or postintervention)).tw.
41. (impact$ or intervention$ or chang$ or outcome$).tw.
42. effect$.tw.
43. or/37-42
44. 36 and 43
45. animals/ not (human/ and animals/
46. 44 not 45
47. 29 or 46
48. 47 and 9
49. limit 48 to yr=“1993 - 2008
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Appendix 2. EMBASE (Ovid) search strategy
1. mobile phone/
2. wireless communication/
3. (cellular phone* or cellular telephon* or cell phone* ormobile phone* ormobile telephon* or wireless phone* or wireless telephon*).ti.
4. 1 or 2 or 3
5. limit 4 to abstracts
6. (cellular phone* or cellular telephon* or cell phone* ormobile phone* ormobile telephon* orwireless phone* orwireless telephon*).tw.
7. (text* or messag* or multimedia or multi-media or imag* or data or input* or sms or mms).tw.
8. (5 or 6) and 7
9. 4 not 5
10. (text messag* or texting or texted).tw.
11. (short messag* or (sms not (somatostatin* or sphingomyelin*))).tw.
12. (multimedia messag* or multi-media messag*).tw.
13. (mms and (multimedia or multi-media)).tw.
14. or/8-13
15. Randomized Controlled Trial/
16. random*.tw.
17. experiment*.tw.
18. time series.tw.
19. (pre test or pretest or post test or posttest).tw.
20. impact.tw.
21. intervention*.tw.
22. chang*.tw.
23. evaluat*.tw.
24. effect?.tw.
25. compar*.tw.
26. control*.tw.
27. or/15-26
28. nonhuman/
29. 27 not 28
30. 14 and 29
31. limit 30 to yr=”1993-2009“
Appendix 3. PsycINFO (Ovid) search strategy
1. (cellular phone* or cellular telephon* or cell phone* ormobile phone* ormobile telephon* orwireless phone* orwireless telephon*).tw.
2. (text* or messag* or multimedia or multi-media or imag* or data or input* or sms or mms).tw.
3. 1 and 2
4. (text messag* or texting or texted).tw.
5. (short messag* or sms).tw.
6. (multimedia messag* or multi-media messag*).tw.
7. (mms and (multimedia or multi-media)).tw.
8. or/3-7
9. random*.tw.
10. experiment*.tw.
11. trial.tw.
12. placebo.ab.
13. groups.ab.
14. ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).tw.
15. time series.tw.
16. time series/
17. (pre test or pretest or post test or posttest).tw.
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18. (pre intervention or preintervention or post intervention or postintervention).tw.
19. (cross over or crossover).tw.
20. latin square.tw.
21. (prospective* or volunteer*).tw.
22. impact.tw.
23. intervention*.tw.
24. chang*.tw.
25. evaluat*.tw.
26. effect?.tw.
27. compar*.tw.
28. control*.tw.
29. treatment effectiveness evaluation/
30. mental health program evaluation/
31. exp experimental design/
32. or/9-31
33. limit 32 to human
34. limit 33 to yr=”1993-2008“
35. (health* or medic* or telemedic* or patient* or illness* or therap* or psychiatr* or nurs* or remind* or consult*).tw.
36. (”27“ or ”32“ or ”33“ or ”34“).cc.
37. 35 or 36
38. 8 and 34
39. 38 and 37
Appendix 4. CENTRAL search strategy
#1 ”cellular phone“:kw or ”mobile phone“:kw or ((text next messag*) or texting or texted or (short next messag*) or (sms not
(somatostatin* or sphingomyelin*)) or (multimedia next messag*) or (multi-media next messag*) or (mms and (multimedia or multi-
media)) or (cellular next phone*) or (cellular next telephon*) or (cell next phone*) or (mobile next phone*) or (mobile next telephon*)
or (wireless next phone*) or (wireless next telephon*)):ti,ab in Clinical Trials
#2 human*:kw in Clinical Trials
#3 #1 and #2
Appendix 5. CINAHL (EBSCO) search strategy
S15 s14
S14 S10 or S13
S13 s11 and s12
S12 PT Research
S11 S3 not S10
S10 s3 and s9
S9 S4 or S5 or S6 or S7 or S8
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(Continued)
S8 pre test or pretest or post test or posttest or pre intervention or preintervention or post intervention or postintervention or
time series
S7 TI ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)) or AB ((singl* or doubl* or trebl* or tripl*) and (blind* or
mask*))
S6 random* or trial or groups or placebo* or experiment* or control* or compar* or intervention* or chang* or evaluat* or impact*
or effect?
S5 PT Clinical Trial
S4 MH Experimental Studies+ or MH Random Assignment or MH Comparative Studies or MH Comparative Studies or MH
Crossover Design or MH Placebos or MH Quantitative Studies or MH Quasi-Experimental Studies+
S3 S1 or S2
S2 cellular phone* or cellular telephon* or cell phone* or mobile phone* or mobile telephon* or wireless phone* or wireless
telephon* or text messag* or texting or texted or short messag* or sms or multimedia messag* or multi-media messag* or (mms
and (phone* or telephon* or multimedia or multi-media or messag*))
S1 MHWireless Communications
Appendix 6. African Health Anthology search strategy
1 - Query 1:
KEY WORDS/PHRASES RANDOM* OR TRIAL* OR CONTROL* OR PROSPECTIV* OR VOLUNTEER* OR EXPERI-
MENT* OR TIME SERIES OR PRE TEST OR PRETEST OR POST TEST OR POSTTEST OR
PRE INTERVENTION OR PREINTERVENTION OR POST INTERVENTION OR POSTIN-
TERVENTION OR IMPACT* OR INTERVENTION* OR CHANG* OR EFFECT*
TITLE PLACEBO OR GROUPS
INDEX TERMS RESEARCH DESIGN OR FOLLOW UP STUDIES OR PROSPECTIVE STUDIES OR CROSS
OVER STUDIES OR DRUG THERAPY
2 - Query 2:
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KEY WORDS/PHRASES ((TEXT* OR MESSAG* OR MULTIMEDIA OR MULTI-MEDIA OR IMAG* OR DATA OR
INPUT* OR SMS OR MMS) AND (CELLULAR PHONE* OR CELLULAR TELEPHON* OR
CELL PHONE* OR MOBILE PHONE* OR MOBILE TELEPHON* OR WIRELESS PHONE*
ORWIRELESS TELEPHON*)) OR TEXT MESSAG* OR TEXTING OR TEXTED OR SHORT
MESSAG* OR (SMS NOT (SOMATOSTATIN* OR SPHINGOMYELIN*)) OR MULTIMEDIA
MESSAG*ORMULTI-MEDIAMESSAG*OR (MMSAND(MULTIMEDIAORMULTI-MEDIA)
)
TITLE CELLULARPHONE*ORCELLULARTELEPHON*ORCELLPHONE*ORMOBILEPHONE*
OR MOBILE TELEPHON* OR WIRELESS PHONE* OR WIRELESS TELEPHON*
INDEX TERMS CELLULAR PHONE
3 - Query 1 and Query 2.
Appendix 7. Search Strategy for LILACS, trial portals and grey literature
“cellular phone” OR “mobile phone” OR cellular telephone* OR mobile telephone* OR text messag* OR texting OR texted OR short
messag* OR multimedia messag* OR sms OR mms
Appendix 8. Data synthesis methods
We will consider whether it is appropriate to combine the studies quantitatively once we have completed the search. The decision is
likely to rest on the diversity of interventions and outcome measures used in the studies. Studies will be classified on the following
issues:
• Study design: RCTs, QRCTs, CBAs, ITS;
• Outcome measures used, as described at Types of outcome measures.
If quantitative analysis is undertaken, themeta-analysiswill dependon the outcomes reported. For continuous data, where outcomes have
been measured in a standard way across studies, we will report the SMD and confidence intervals (Alderson 2002b). For dichotomous
data, when outcomes have been measured in a standard way, we will report the RR. In such cases, a cautious approach will be taken to
combining results, and the rationale will be detailed. We will conduct statistical analysis according to the guidelines in the Cochrane
Handbook (Higgins 2011).
H I S T O R Y
Protocol first published: Issue 4, 2008
Review first published: Issue 6, 2012
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consumer perspectives and will be responsible for leading the update of this review.
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and interpreted data and contributed to writing the review, providing methodological and policy perspectives.
Vlasta Vodopivec Jamek developed the protocols. She has been involved in the screening and quality appraisal process and assisted in
undertaking searches. She has collected, analysed and interpreted data and contributed to writing the review, providing clinical and
consumer perspectives.
Thyra de Jongh coordinated data extraction and management and was involved in the screening and quality appraisal process. She has
collected, analysed and interpreted data and contributed to writing the review, providing a methodological perspective.
Rifat Atun provided general direction for the studies and assisted in writing and revising the review.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Search strategy
We were not able to search the following databases we listed in the protocol:
• Proceedings from the MEDNET Congresses: We could not access the proceedings.
• TrialsCentralTM (www.trialscentral.org): The website for the data base was not functional and did not allow for the search of
clinical trials.
• African Trials Register: The trials in the African Trials Register are collected with a search strategy using the Cochrane Controlled
Trials Register and the African Health Anthology (AHA). As we searched both original sources, it was not necessary to access the
African Trials Register separately.
• Health Star: The database ceased to exist as of December 2000, with all peer-reviewed journal articles transferred to PubMed.
Subgroup analysis
We conducted a post-hoc subgroup analysis according to differences in outcomes for participants who received positive versus negative
results from their medical investigations.
We were unable to conduct subgroup analyses by participant age (0 to 18, 18 to 55, over 55), as planned, because only one study was
included.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Cell Phones; ∗Text Messaging; Anxiety [∗psychology]; Down Syndrome [∗diagnosis]; Prenatal Diagnosis [∗psychology]; Randomized
Controlled Trials as Topic
MeSH check words
Female; Humans; Pregnancy
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